Clinical Trial Update: Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using fish oil (Omega-3 fatty acids) to reduce recurrence of atrial fibrillation after DC cardioversion. The study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Fish oil

Snippet

Sponsor: Melbourne Health | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED